Examining how CDC guidelines affect pain management in older adults with dementia
Official title: Dementia and the opioid epidemic: The impact of the 2016 CDC guidelines on disparities in pain management
Funded at Icahn School of Medicine at Mount Sinai · NIH-10975648 · Data updated 2026-11-12
This study looks at how the 2016 CDC guidelines on prescribing opioids have affected older adults with pain, especially those with Alzheimer's and similar conditions, to see if these rules have made it harder for them to get the pain relief they need.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 17, 2024 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $338,000 |
| NIH project number | 1R03AG082996-01A1 |
| Project ID | NIH-10975648 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include older adults with Alzheimer's disease or related dementias who experience opioid-responsive pain.
✕Less likely to help
Patients who do not have Alzheimer's disease or related dementias and do not experience opioid-responsive pain may not benefit from this research.
What this research studies
This research investigates the effects of the 2016 CDC guidelines on opioid prescribing for older adults suffering from pain, particularly those with Alzheimer's and related dementias. It aims to understand whether these guidelines, intended to reduce opioid misuse, have inadvertently restricted access to necessary pain relief for vulnerable populations. The study will analyze disparities in opioid utilization among older adults, focusing on those with chronic cancer pain and acute orthopedic trauma. By examining these issues, the research seeks to highlight the potential negative consequences of the guidelines on pain management for specific subgroups.
Why it matters
Potential benefit: If successful, this research could lead to improved pain management strategies for older adults with dementia, ensuring they receive appropriate care.
How similar studies have gone: Other research has indicated that guidelines affecting opioid prescribing can have significant impacts on patient care, suggesting that this investigation is both relevant and necessary.
Where this research is happening
-
Icahn School of Medicine at Mount Sinai
New York, United States Active
Researchers
- Principal investigator: Rodin, Rebecca Anne — Icahn School of Medicine at Mount Sinai
- Study coordinator: Rodin, Rebecca Anne
Related research
Other NIH-funded projects on the same topics.
-
Investigating how DNA damage and repair mechanisms are altered in ALS and frontotemporal dementia.
This study is looking at how problems with DNA repair might contribute to conditions like ALS and frontotemporal dementia, and it’s testing ways to fix these issues in cells from patients to help develop new treatments.
-
Synthetic protein mimetics to treat Lewy Body Dementia
A new therapeutic approach using engineered protein-like molecules to block the harmful protein clumps that cause Lewy Body Dementia.
-
Dementia care staff study: adapting a US survey for use in many countries
A study is adapting and testing a survey for dementia care workers in the US, Brazil, Switzerland, and Ghana to help understand why workers stay in their jobs and how to improve care.
-
Dementia care staff study: adapting a survey for use in many countries
A multinational study will adapt and test a U.S. dementia-care worker survey in Brazil, Switzerland, and Ghana to help understand why staff stay in or leave long-term care settings.
-
Study of Dementia Care Staff in 4 Countries: Adapting Caregiver Surveys Across Cultures
A multinational project will adapt and test a dementia care worker survey so researchers can compare care environments across the US, Brazil, Switzerland, and Ghana.
-
New biomarkers to distinguish LATE from Alzheimer’s disease in dementia
A study to develop blood and CSF tests that can tell apart LATE from Alzheimer’s disease in people with dementia.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.